Connect your AI

Opko Health OPK Finance Lease Liabilities

Finance Lease Liabilities at other companies

Amneal Pharmaceuticals, Inc.AMRX

$58.37M-2.9%

Personalis, Inc.PSNL

$1.1M—

Other financials

Income statement

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

Operating cash flow-$19.3M+44.1%

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

Market cap$1.13B+10.0%

P/S1.9×+0.5×

Profitability

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opko Health's finance lease liabilities?: Opko Health (OPK) reported finance lease liabilities of $3.01M in Q1 2026.
How has Opko Health's finance lease liabilities changed year-over-year?: Opko Health's finance lease liabilities decreased by 20.9% year-over-year, from $3.8M to $3.01M.
What is the long-term trend for Opko Health's finance lease liabilities?: Over 5 years (2020 to 2025), Opko Health's finance lease liabilities has grown at a 3.9% compound annual growth rate (CAGR), from $2.81M to $3.39M.
What does finance lease liabilities mean?: Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.